Analysis and characterization of GLP-1 receptor agonists
9 Jul 2026This resource by Waters presents a comprehensive analytical workflow for the analysis and characterization of GLP-1 receptor agonists (GLP-1 RAs), including therapies such as semaglutide, liraglutide, exenatide, dulaglutide, and tirzepatide. It focuses on critical quality attributes (CQAs) including identity, purity, stability, and safety. It also demonstrates how reversed-phase liquid chromatography–mass spectrometry (RPLC-MS), amino acid analysis, peptide mapping, and size-exclusion chromatography with multi-angle light scattering (SEC-MALS) can be used to detect impurities, confirm peptide identity, monitor degradation, and characterize oligomers and aggregates.
Resource details:
- Resource type: Application note
- Page count: 15
- Read time: 26 mins




